Tutorials
Arrowhead Pharmaceuticals Inc logo

Arrowhead Pharmaceuticals Inc

$ 47.29 +1.66 (+3.64%) 08:08 PM EST
P/E:
At Loss
P/B:
11.02
Market Cap:
$ 5.01B
Enterprise V:
$ 4.67B
Volume:
602.08K
Avg Vol (2M):
857.76K
Also Trade In:
Volume:
602.08K
Market Cap $:
5.01B
PE Ratio:
At Loss
Avg Vol (2-Month):
857.76K
Enterprise Value $:
4.67B
PB Ratio:
11.02
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Arrowhead Pharmaceuticals Inc
NAICS : 541714 SIC : 2834
177 E. Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105
Description
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Name Current Vs Industry Vs History
Cash-To-Debt 5.14
Equity-to-Asset 0.6
Debt-to-Equity 0.18
Debt-to-EBITDA -0.54
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.59
Distress
Grey
Safe
Beneish M-Score -2.3
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 64.91
9-Day RSI 63.81
14-Day RSI 62.87
6-1 Month Momentum % -18.07
12-1 Month Momentum % -30.59

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.37
Quick Ratio 3.37
Cash Ratio 3.25
Days Sales Outstanding 3.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.6

Financials (Next Earnings Date:2022-11-22 Est.)

ARWR's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ARWR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 249.939
EPS (TTM) ($) -1.48
Beta 1.18
Volatility % 43.12
14-Day RSI 62.87
14-Day ATR ($) 2.388272
20-Day SMA ($) 44.093
12-1 Month Momentum % -30.59
52-Week Range ($) 26.81 - 84.83
Shares Outstanding (Mil) 105.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arrowhead Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More